Showing results (811-820 of 3,336) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|September 11, 2026
Differential metabolic and cellular brain regional susceptibility in adult rats with chronic liver diseaseDunja Simicic, Katarzyna Pierzchala, Olivier Braissant, et al.Metabolic Brain Disease|September 10, 2026
Lactate as a metabolic-epigenetic hub in neurological disordersYu Gu, Potao Zhang, Chunyan LeiMetabolic Brain Disease|September 14, 2026
Significance of NAD anabolism profiles in neurological diseasesAbhishek Kumar Mishra, Dipak Kumar, Sakshi Jaiswal, et al.Metabolic Brain Disease|October 13, 2026
Blood-based multiplex nanobiosensing of Alzheimer's disease biomarkers: from nanoengineered ınterfaces to clinical translationZilan Nupelda Pehlivan, Kaan Zıkşahna, Rumeysa Adıyıl, et al.Metabolic Brain Disease|October 19, 2026
Serum miR-329-3p as a potential biomarker for ischemic stroke: clinical association and in vitro neuroprotection via PTPN1Haitao Fang, Qi Zhou, Huihui Wang, et al.Metabolic Brain Disease|June 1, 2001
Glycosylation of transferrin in Alzheimer's disease and alcohol-induced dementiaS J van Rensburg, P A Berman, F C Potocnik, et al.Metabolic Brain Disease|June 1, 2001
Detection of tissue kallikrein and kinin B1 and B2 receptor mRNAs in human brain by in situ RT-PCRR Mahabeer, S Naidoo, D M RaidooMetabolic Brain Disease|June 27, 2002
Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acidsV M T Trindade, A M Brusque, J R Raasch, et al.Metabolic Brain Disease|January 26, 2000
Effect of alcohol on energy storage of primary astrocytes and C6-glioma cells in vitroN Haghighat, D W McCandless, P GeraminejadMetabolic Brain Disease|June 1, 2001
An investigation into the neuroprotective properties of ibuprofenZ Lambat, N Conrad, S Anoopkumar-Dukie, et al.Pageof 334